PLx Pharma
Houston
About PLx Pharma
PLx Pharma is a pharmaceutical company that develops and commercializes non-steroidal anti-inflammatory drugs (NSAIDs) for prescription and over-the-counter markets in the United States. The company offers PL2200 Aspirin, a molecular complex of aspirin and phosphatidylcholine; and PL1100/1200 Ibuprofen, which are oral drug products containing a molecular complex of ibuprofen and phosphatidylcholine.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $89.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2021)
- Ticker: nasdaq:PLXP
- Website: plxpharma.com
- Phone: 713-842-1249
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/plx-pharma-171771 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.